Julia Coronella

917 total citations
19 papers, 650 citations indexed

About

Julia Coronella is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Julia Coronella has authored 19 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Julia Coronella's work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (2 papers). Julia Coronella is often cited by papers focused on CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (2 papers). Julia Coronella collaborates with scholars based in United States. Julia Coronella's co-authors include Bruce J. Cochrane, Piotr Zimniak, Sharda P. Singh, Helen Beneš, Hugo O. Villar, Evan M. Hersh, Alison Stopeck, Catherine Spier, Matthew Welch and Katrina T. Trevor and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Julia Coronella

18 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Coronella United States 11 304 250 228 98 92 19 650
Sylvia Laffer Austria 23 275 0.9× 65 0.3× 223 1.0× 188 1.9× 17 0.2× 46 1.8k
Linhong Li United States 16 571 1.9× 261 1.0× 251 1.1× 13 0.1× 112 1.2× 35 924
Nge Cheong Singapore 16 436 1.4× 168 0.7× 71 0.3× 33 0.3× 17 0.2× 27 734
Muhammad Nadeem Abbas China 12 157 0.5× 108 0.4× 193 0.8× 40 0.4× 56 0.6× 16 402
Yue Qi China 13 219 0.7× 130 0.5× 128 0.6× 14 0.1× 28 0.3× 39 587
Sébastien Durand France 13 568 1.9× 95 0.4× 252 1.1× 8 0.1× 108 1.2× 19 852
Andrés Tittarelli Chile 20 475 1.6× 243 1.0× 337 1.5× 14 0.1× 10 0.1× 34 896
Tim Gabriele Australia 5 483 1.6× 118 0.5× 38 0.2× 15 0.2× 41 0.4× 6 581

Countries citing papers authored by Julia Coronella

Since Specialization
Citations

This map shows the geographic impact of Julia Coronella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Coronella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Coronella more than expected).

Fields of papers citing papers by Julia Coronella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Coronella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Coronella. The network helps show where Julia Coronella may publish in the future.

Co-authorship network of co-authors of Julia Coronella

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Coronella. A scholar is included among the top collaborators of Julia Coronella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Coronella. Julia Coronella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jambon, Samy, Meixuan Chen, Rajesh Belani, et al.. (2024). P-CD19CD20-ALLO1: Potent Fully Allogeneic CAR-T Therapy Targeting CD19 and CD20 with Superior Efficacy over Single-Target Products. Blood. 144(Supplement 1). 4805–4805.
2.
3.
Haag, Sabrina, Katherine McArthur, Samuel E. DePrimo, et al.. (2024). Abstract CT070: Solid tumor patients require higher cyclophosphamide (cy) dose than multiple myeloma (MM) patients to achieve adequate lymphodepletion (LD) necessary to enable allogeneic CAR-T expansion. Cancer Research. 84(7_Supplement). CT070–CT070. 2 indexed citations
4.
Madison, Blair, Deepak P. Patil, Maximilian Richter, et al.. (2022). Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells. Molecular Therapy — Nucleic Acids. 29. 979–995. 41 indexed citations
5.
Slovin, Susan F., Tanya B. Dorff, Gerald S. Falchook, et al.. (2022). Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 40(6_suppl). 98–98. 29 indexed citations
6.
Henry, Jason T., David Oh, Joaquina Baranda, et al.. (2022). 728 Phase 1 study of P-MUC1C-ALLO1 allogeneic CAR-T cells in patients with epithelial-derived cancers. Regular and Young Investigator Award Abstracts. A761–A761. 12 indexed citations
7.
Tseng, Hubert, Yan Zhang, Stacey Cranert, et al.. (2021). 147 Memory phenotype in allogeneic anti-BCMA CAR-T cell therapy (P-BCMA-ALLO1) correlates with in vivo tumor control. SHILAP Revista de lepidopterología. A155–A155. 1 indexed citations
8.
Tseng, Hubert, Yan Zhang, Stacey Cranert, et al.. (2021). Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control. Blood. 138(Supplement 1). 4802–4802. 5 indexed citations
9.
Fujita, Ryo, Vincent Blot, Christine P. Stewart, et al.. (2020). A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers. Cancer Biology & Therapy. 21(6). 549–559. 17 indexed citations
10.
Kozłowska, Anna, Yan Zhang, Steven Wang, et al.. (2020). 120 P-MUC1C-ALLO1: An allogeneic car-t for multiple solid tumor indications. SHILAP Revista de lepidopterología. A73.1–A73. 4 indexed citations
11.
12.
Blot, Vincent, et al.. (2014). The New Generation of Antibody Drug Conjugates. 5(1-2). 25–45. 1 indexed citations
13.
Liu, Dingguo, Haim Moskowitz, Anouk Dirksen, et al.. (2013). The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs. Translational Oncology. 6(5). 562–IN6. 32 indexed citations
14.
Pirie‐Shepherd, Steven, et al.. (2012). Abstract 4629: Tumor penetration and retention of different sized FGFR4 targeting scaffolds. Cancer Research. 72(8_Supplement). 4629–4629. 8 indexed citations
15.
Coronella, Julia, et al.. (2009). Selective activity against proliferating tumor endothelial cells by CVX-22, a thrombospondin-1 mimetic CovX-Body.. PubMed. 29(6). 2243–52. 17 indexed citations
16.
Coronella, Julia, Catherine Spier, Matthew Welch, et al.. (2002). Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast. The Journal of Immunology. 169(4). 1829–1836. 131 indexed citations
17.
Singh, Sharda P., Julia Coronella, Helen Beneš, Bruce J. Cochrane, & Piotr Zimniak. (2001). Catalytic function of Drosophila melanogaster glutathione S‐transferase DmGSTS1‐1 (GST‐2) in conjugation of lipid peroxidation end products. European Journal of Biochemistry. 268(10). 2912–2923. 235 indexed citations
18.
Coronella, Julia, et al.. (2001). Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.. PubMed. 61(21). 7889–99. 67 indexed citations
19.
Coronella, Julia. (2000). Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells. Nucleic Acids Research. 28(20). 85e–85. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvia Laffer Breakdown of academic impact, for papers by Linhong Li Breakdown of academic impact, for papers by Nge Cheong Breakdown of academic impact, for papers by Muhammad Nadeem Abbas Breakdown of academic impact, for papers by Yue Qi Breakdown of academic impact, for papers by Sébastien Durand Breakdown of academic impact, for papers by Andrés Tittarelli Breakdown of academic impact, for papers by Tim Gabriele
Rankless by CCL
2026